Bilirubin and lactate: easy to determine and valuable to predict outcome in cardiac surgery.


Journal

The Journal of cardiovascular surgery
ISSN: 1827-191X
Titre abrégé: J Cardiovasc Surg (Torino)
Pays: Italy
ID NLM: 0066127

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 11 2 2021
medline: 22 6 2021
entrez: 10 2 2021
Statut: ppublish

Résumé

Cardiopulmonary bypass during cardiac surgery is associated with metabolic changes after operation and results inter alia in increased levels of lactate and bilirubin. Since prediction of the course after operation has become very important for the management of an ICU and the patients themselves, we evaluated easily assessable markers (lactate and bilirubin), regarding their potential to predict mortality 90 days after surgery and the length of stay in ICU. All patients within a period of five years undergoing cardiac surgery were enrolled in the study. Among others peak levels of lactate and bilirubin within 48 hours after operation were recorded. A Cox proportional hazard model as well as a logistic regression model were used to predict mortality or rather length of stay in ICU. Increased levels of bilirubin and lactate were associated with a significantly increase in mortality and length of stay in ICU (in a concentration-related manner). Interestingly, creatinine serum levels before operation showed a similar performance. Three easily assessable and cheap laboratory parameters (bilirubin, lactate, and creatinine) are useful to predict 90-day mortality and length of stay in ICU. These findings might be helpful to give patients a reliable prediction about short and mid-term-survival and to improve the management of an ICU.

Sections du résumé

BACKGROUND BACKGROUND
Cardiopulmonary bypass during cardiac surgery is associated with metabolic changes after operation and results inter alia in increased levels of lactate and bilirubin. Since prediction of the course after operation has become very important for the management of an ICU and the patients themselves, we evaluated easily assessable markers (lactate and bilirubin), regarding their potential to predict mortality 90 days after surgery and the length of stay in ICU.
METHODS METHODS
All patients within a period of five years undergoing cardiac surgery were enrolled in the study. Among others peak levels of lactate and bilirubin within 48 hours after operation were recorded. A Cox proportional hazard model as well as a logistic regression model were used to predict mortality or rather length of stay in ICU.
RESULTS RESULTS
Increased levels of bilirubin and lactate were associated with a significantly increase in mortality and length of stay in ICU (in a concentration-related manner). Interestingly, creatinine serum levels before operation showed a similar performance.
CONCLUSIONS CONCLUSIONS
Three easily assessable and cheap laboratory parameters (bilirubin, lactate, and creatinine) are useful to predict 90-day mortality and length of stay in ICU. These findings might be helpful to give patients a reliable prediction about short and mid-term-survival and to improve the management of an ICU.

Identifiants

pubmed: 33565745
pii: S0021-9509.21.11538-1
doi: 10.23736/S0021-9509.21.11538-1
doi:

Substances chimiques

Biomarkers 0
Lactic Acid 33X04XA5AT
Bilirubin RFM9X3LJ49

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-398

Auteurs

Benjamin Luchting (B)

Department of Anesthesiology, University of Munich (LMU), Munich, Germany.
Unit of Interdisciplinary Pain Center, Klinikum Landsberg am Lech, Landsberg am Lech, Germany.

Lorenz Mihatsch (L)

Unit of Statistical Consulting StaBLab, Department of Statistics, University of Munich (LMU), Munich, Germany.

Anastasiia Holovchak (A)

Unit of Statistical Consulting StaBLab, Department of Statistics, University of Munich (LMU), Munich, Germany.

Ruben WIßKOTT (R)

Unit of Statistical Consulting StaBLab, Department of Statistics, University of Munich (LMU), Munich, Germany.

Alexey Dashkevich (A)

Department of Cardiac Surgery, University of Munich (LMU), Munich, Germany.

Isabel Kiesewetter (I)

Department of Anesthesiology, University of Munich (LMU), Munich, Germany.

Erich Kilger (E)

Department of Anesthesiology, University of Munich (LMU), Munich, Germany.

Jens Heyn (J)

Department of Anesthesiology, University of Munich (LMU), Munich, Germany - jens.heyn@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH